Based out of Barcelona, Dinbeat is a startup specialised in the development of innovative and technological products for the pet sector. Recently, the Spanish company has also secured €500K funding led by current partners, investors from the IESE Business Angels Network, Afintia, Accelgrow, veterinary professionals, and other business angels who already were aware of the project.
Talía Bonmatí, CEO and Founder of Dinbeat, has assured that “with this round, Dinbeat hopes to consolidate its position in the veterinary sector in 2020, and to open a new line of health tech business in parallel in 2021, once the technology is validated for human-use. Telemedicine is here to stay and we want to lead the change ”.
Validating its technology for human-use!
The funding will allow the company to reinforce its internationalisation strategy during 2020 and unlocks the Enisa Growth Spanish participative loan. Additionally, it will allow the company to grow its team, reinforcing the areas of marketing, sales, development, and helping to validate its technology for human-use by the Germans Trias i Pujol Hospital (Can Ruti) in Badalona, Spain.
Wirelessly monitor pets in real time!
Founded by David Arranz, Francisco Gil, and Talia Bonmati in 2016, Dinbeat launched Dinbeat UNO last year, a wearable device for professional veterinary use, that wirelessly monitors pets’ health in real-time, gathering information about electrocardiogram, heart rate, respiration per minute and temperature, among other metrics.
On the other hand, the company has developed Dinbeat Life, a device to monitor human health. This device allows an unlimited number of patients to be controlled from the same central unit and also receive alerts when any patient requires medical attention. This will open up endless possibilities for remote patient monitoring.
Dinbeat has so far had the support of entities such as CDTI, Enisa, Acció, Barcelona Activa, IQS, UAB, Microsoft for Startups, Google for Startups, Garage + Asia, Esade, the University of Murcia, and Animal Biosciences, a company Owned by Life Biosciences, an American business group based in Boston that focuses its investments in the field of health and with which it closed its first round of investment.
Main image credits: Dinbeat
Stay tuned to Silicon Canals for more European technology news